Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
Addressing the silent killer: How Iowans can reduce their risk for heart disease and live heart-healthy lives ...
Emilia Pérez” star and Oscar nominee Karla Sofía Gascón has issued an apology after her social media posts expressing ...
Like a typical teenager, Abby Weiss guts through her nightly homework. But she also is gutting through the near-constant pain ...